S-Allylmercaptocysteine Targets Nrf2 in Osteoarthritis Treatment Through NOX4/NF-κB Pathway

S-Allylmercaptocysteine Targets Nrf2 in Osteoarthritis Treatment Through NOX4/NF-κB Pathway

Guang Yang,1 Shui Sun,1 Jian Wang,1 Wei Li,1 Xianquan Wang,1 Lin Yuan,1 Siying Li2 1Department of Joint Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong, People’s Republic of China; 2Department of Physiology & Pathophysio...

Full description

Bibliographic Details
Main Authors: Yang G, Sun S, Wang J, Li W, Wang X, Yuan L, Li S
Format: Article
Language:English
Published: Dove Medical Press 2020-10-01
Series:Drug Design, Development and Therapy
Subjects:
s-allylmercaptocysteine
nrf2
osteoarthritis
oxidative stress
inflammation
Online Access:https://www.dovepress.com/s-allylmercaptocysteine-targets-nrf2-in-osteoarthritis-treatment-throu-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/s-allylmercaptocysteine-targets-nrf2-in-osteoarthritis-treatment-throu-peer-reviewed-article-DDDT

Similar Items